PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12690667

[Fluctuations].

Ph Damier
View original source ↗Export metadata ↓

Abstract

Fluctuations in the efficacy of dopaminergic treatment are defined as the intermittent recurrence of parkinsonian features during the day. After a disease duration of 5 years, over 50 p. 100 of patients already experience this complication, due both to disease progression and the treatment itself. We are now starting to understand the mechanisms responsible for fluctuations: while pharmacokinetic alterations of dopamine in the brain (i.e. a reduction in dopamine storage capacity) are clearly involved, there are also complex postsynaptic anomalies, affecting all the basal ganglia circuity. A careful semiologic analysis will help to establish the precise chronology of the fluctuations and their position with respect to drug intake. This is an essential step before any attempt is made to correct them.

Explore related subjects

DopamineHumansParkinson DiseaseRecurrenceSurveys and QuestionnairesEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ph Damier. 2002. [Fluctuations].. https://pubmed.ncbi.nlm.nih.gov/12690667/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

Determination of dopamine by flow-injection analysis coupled with luminol-hexacyanoferrate(III) chemiluminescence detection.

A novel flow-injection method (FIA) for the determination of dopamine based on the inhibition of the intensity of chemiluminescence (CL) from luminol-hexacyanoferrate(III) system in basic medium is described. The present method allows the determination of dopamine over the range 30-100 microg l(-1) and 400-3000 microg l(-1). The relative standard deviation is 2.32% for 70 microg l(-1) dopamine and 1.22% for 1500 microg l(-1) dopamine (n = 20). The detection limit is 5 microg l(-1) with the sampling rate of 135 samples h(-1). This method has been applied for the determination of dopamine in commercial pharmaceutical injection samples. The results obtained by this method agreed with those by the official method.

Dopamine↗
PubMed2004

Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles.

We report on the use of dopamine (DA) as a robust molecular anchor to link functional molecules to the iron oxide shell of magnetic nanoparticles. Using nitrilotriacetic acid (NTA) as the functional molecule, we created a system with an M/Fe2O3-DA-NTA (M = Co or SmCo5.2) nanostructure, which possesses high stability and specificity for separating histidine-tagged proteins. The well-established biocompatibility of iron oxide and the robust covalent bonds between DA and Fe2O3 render this strategy attractive for constructing biofunctional magnetic nanoparticles containing iron oxide.

Dopamine↗
PubMed2004

Electrochemical investigation of dopamine at the water/1,2-dichloroethane interface.

Dopamine is an important neurotransmitter in mammalian central and peripheral nervous systems and is also a medicament to cure some neuropsychosis. In this work, ion transfer (IT), facilitated ion transfer (FIT) of protonated dopamine, and electron transfer (ET) between dopamine and ferrocene are investigated at the water/1,2-dichloroethane (W/DCE) interface. The IT and FIT reactions of protonated dopamine can be observed simultaneously within the same potential window. The experimental results demonstrate that dibenzo-18-crown-6, dibenzo-24-crown-8, and benzo-15-crown-5 work well with the protonated dopamine. The amperometric detection of dopamine based on either the IT or the FIT of protonated dopamine can get rid of the interference of ascorbic acid, and the lowest concentration that can be determined is approximately 0.05 microM by differential pulse voltammetry. For the ET reaction, its kinetics can be evaluated by scanning electrochemical microscopy, and the results show that the relationship between rate constants and driving force at the unmodified W/DCE interface obeys the Butler-Volmer equation in a rather wide potential region. When the W/DCE interface is modified by egg lecithin, the ET rate constants decrease with increasing concentration of egg lecithin, which indicates that egg lecithin hinders the ET reaction. When the driving force is increased to a certain degree, the linear relationship between ET rate constants and the driving force is distorted. These results will be helpful to understand both the pharmacodynamics and the neural signal transmission mechanism of dopamine at biological membranes and also provide a novel way to detect dopamine.

Dopamine↗